Filing Details

Accession Number:
0001171843-17-005396
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-09-05 20:10:59
Reporting Period:
2017-08-31
Accepted Time:
2017-09-05 19:10:59
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
722830 Immunomedics Inc IMMU In Vitro & In Vivo Diagnostic Substances (2835) 611009366
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1202016 L Cynthia Goldenberg C/O Immunomedics, Inc.
300 The American Road
Morris Plains NJ 07950
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2017-08-31 5,000 $12.25 793,219 No 4 S Direct
Common Stock Disposition 2017-08-31 5,000 $12.50 788,219 No 4 S Direct
Common Stock Disposition 2017-09-01 10,000 $12.90 778,219 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 5,128,014 Indirect See Footnote
Footnotes
  1. Includes a total of 635,935 shares held as joint tenants by the reporting person and her spouse, David M. Goldenberg, a director of the issuer and the Issuer's Chief Scientific Officer and Chief Patent Officer.
  2. Such shares are held by the reporting person's spouse, by various trusts established for the benefit of the reporting person and/or family members of the reporting person, or by a majority-owned subsidiary of the Issuer, of which the reporting person is an officer. The reporting person disclaims beneficial ownership of these shares except to the extent of her pecuniary interests therein.